BDBM524421 2-((2S,4R)-4-amino-1-(6- (trifluoromethyl)imidazo[1,2- a]pyridine-2-carbonyl)pyrrolidin-2-yl)- N-((S)-6-guanidino-1-(methylamino)- 1-oxohexan-2-yl)thiazole-4- carboxamide::US11168083, Example 19

SMILES CNC(=O)[C@H](CCCCNC(N)=N)NC(=O)c1csc(n1)[C@@H]1C[C@@H](N)CN1C(=O)c1cn2cc(ccc2n1)C(F)(F)F

InChI Key InChIKey=KOVNKSCBSLWDLG-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 524421   

TargetPlasma kallikrein(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM524421(2-((2S,4R)-4-amino-1-(6- (trifluoromethyl)imidazo[...)
Affinity DataEC50: <100nMAssay Description:Plasma Kallikrein: The example compounds were evaluated for inhibition of the human activated kallikrein enzyme in two formats of an assay employing ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent